Panelists:
- Stacy Melanson, MD, Ph.D., Director of Clinical Laboratories, Brigham & Women’s Hospital and Associate Professor of Pathology, Harvard Medical School
- Omai Garner, Ph.D., Associate Professor, Pathology and Laboratory Medicine at UCLA Health System
- Bart Buxton, Ed.D, President & CEO for the McLaren Health Management Group
Moderator: Laura Parnas, Ph.D., Senior Scientific Affairs Manager, Roche Diagnostics
Length: 56 minutes
Summary: This diverse panel discussion approaches the topic of COVID-19 diagnostics on subjects like testing algorithms, critical care patient management, and population health management with vaccines on the horizon.
Learning Objectives:
- Recognize the value of the lab in the adoption and implementation of COVID testing algorithms into a healthcare system
- Distinguish the roles of molecular, antigen, and serological testing in the context of SARS-CoV-2 diagnosis and population management
- Translate considerations for preparation and planning in the integration of novel COVID-19 diagnostic tests to their institution
